Study Stopped
Lack of efficacy
An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)
Gatekeeper® System Sham-Controlled Study for the Treatment of GERD
1 other identifier
interventional
143
2 countries
11
Brief Summary
The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2002
Longer than P75 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 20, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedJuly 13, 2009
July 1, 2009
3.5 years
September 12, 2005
July 10, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in serious device and procedure related adverse device effects.
6 months
Secondary Outcomes (1)
Improvement in espophageal pH
6 months
Study Arms (2)
Sham
SHAM COMPARATORThis arm of the study has the procedure but does not get the Gatekeeper prostheses. The Sham arm has the option to cross-over to the Treatment arm at the 6-month visit.
Treatment
ACTIVE COMPARATORThe treatment arm has the Gatekeeper devices implanted.
Interventions
The Gatekeeper System™ consists of a specialized 16-mm overtube assembly, a 2.4-mm diameter prosthesis delivery system (1-mm diameter needle, dilator, and 2.4-mm diameter sheath), a pushrod assembly and Gatekeeper Prosthesis. Up to 4 prostheses will be implanted at the initial procedure and retreatment with up to four more prostheses will be allowed at 3-months if the subject has a GERD HRQL score \>15.
Eligibility Criteria
You may qualify if:
- Subjects diagnosed with GERD with symptomatic improvement on PPIs.
- Subjects who have demonstrated a baseline 24 Hour pH ≥ 4% time with pH ≤ 4.0.
- Subjects with a baseline GERD-HRQL heartburn score of ≤11 on PPI and ≥ 20 off PPI.
You may not qualify if:
- Extensive Barrett's Esophagus (\> 2 cm).
- Esophagitis (LA Classification Grades C or D).
- Previous history of gastroesophageal surgery, anti-reflux procedures, or gastroesophageal or gastric cancer.
- Large hiatal hernia (\> 3 cm).
- Current complaints of clinical dysphagia evidenced by greater than one occurrence per month.
- Esophageal strictures
- Esophageal or gastric varices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MedtronicNeurolead
Study Sites (11)
Contact Medtronic for specific site information
San Francisco, California, 94115, United States
Contact Medtronic for specific site information
Atlanta, Georgia, 30322, United States
Contact Medtronic for specific site information
Chicago, Illinois, 60611, United States
Contact Medtronic for specific site information
Indianapolis, Indiana, 46202, United States
Contact Medtronic for specific site information
Lexington, Kentucky, 40536, United States
Contact Medtronic for specific site information
St Louis, Missouri, 63110, United States
Contact Medtronic for specific site information
Lebanon, New Hampshire, 03756, United States
Contact Medtronic for specific site information
New York, New York, 10021, United States
Contact Medtronic for specific site information
Knoxville, Tennessee, 37909, United States
Contact Medtronic for specific site information
Milwaukee, Wisconsin, 53233, United States
Contact Medtronic for specific site information
Amsterdam, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glen Lehman
Indiana University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 20, 2005
Study Start
December 1, 2002
Primary Completion
June 1, 2006
Study Completion
June 1, 2008
Last Updated
July 13, 2009
Record last verified: 2009-07